»ï¼º¼¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21 |
|
»ï¼º¼¿ïº´¿ø ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ILD School 2020 : 2020-03-21 ±³À°ÀÏÀÚ : 2020-03-21 ±³À°Àå¼Ò : »ï¼º¼¿ïº´¿ø º»°ü ÁöÇÏ1Ãþ ´ë°´ç ±³À°ÁÖÁ¦ : ILD School 2020 ÁÖÃÖ±â°ü : ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ ½ÃÇà±â°ü(ÁöºÎ/°ú) : °£Áú¼ºÆóÁúȯ(ILD)¿¬±¸È¸ ´ã´çÀÚ : ±è½ÃÀ± ¿¬¶ôó : 02-575-3825 À̸ÞÀÏ : katrd@hanmail.net ±³À°Á¾·ù : ³»°ú, °áÇÙ°ú Âü¼®¿¹»óÀοø : 100¸í Èñ¸ÁÆòÁ¡ : 3Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ ¼¼ºÎ¼ö°·á : 10,000¿ø ºñ°í »çÀüµî·Ï : 10,000¿ø ÇöÀåµî·Ï : 20,000¿ø ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°´ç 14:10~14:40 Idiopathic Pulmonary Fibrosis: Current Management and Future Perspectives ÃÖ¼±¹Ì(¼¿ïÀÇ´ë ³»°ú) ±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°´ç 14:40~15:10 An Evolving ILD : Pleuroparenchymal Fibroelastosis ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë ³»°ú) ±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°´ç 15:10~15:40 Diagnostic Approach to Diffuse Cystic Lung Disease: Radiologists¡¯ Perspectives äÀºÁø(¿ï»êÀÇ´ë ³»°ú) ±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°´ç 16:10~16:40 Progressive Fibrosing-ILD: Concept and Pharmacologic Management ¼ÛÁø¿ì(¿ï»êÀÇ´ë ³»°ú) ±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°´ç 16:40~17:10 Systemic Sclerosis Associated ILD: where do we stand ÀÌÁ¾¹Î(°¡Å縯ÀÇ´ë ³»°ú) ±³À°½Ã°£ 03-21 ÁöÇÏ1Ãþ ´ë°´ç 17:10~17:40 Chronic Hypersensitivity Pneumonitis: the New Diagnostic Criteria and Treatment À¯È«¼®(¼º±Õ°üÀÇ´ë ³»°ú) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 305 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 410 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 344 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 366 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 5,795 , ´ñ±Û¼ö : 0 |